Case Study : Rapidly Diffusing New Knowledge On Novel Medicines For COVID-19 In India | Viatris

✅ Download the Whitepaper: https://bit.ly/3Rt0k8p Learn how a leading maker of medicines for the global market reached > 65,000 healthcare professionals across India to bridge the knowledge gap on new COVID 19 treatments and patient management.

Please click here to download whitepaper: https://bit.ly/3Rt0k8p

At a glance
A leading maker of medicines for global markets used MLH to host 69 knowledge­sharing webinars on COVID-19 during 2020 and 2021, attracting 65,448 registrations from healthcare providers.

Challenges
Mylan, a Viatris company, is a global top 5 generics pharmaceutical that was licensed to supply two anti-viral medicines that had recently, in the year 2020, been approved by the European Union and U.S. Food & Drug Administration for use with COVID-19 patients. Given India's skyrocketing COVID-19 cases at that time, there was an urgent need to increase clinician knowledge and confidence about managing COVID-19 patients with these important new treatments. But how to reach the millions of healthcare providers (HCPs) across India's vast and diverse healthcare community, within a short time?

Solutions
Tech Care for All (TC4A) approached Mylan with a plan to spread scientific evidence-based awareness and engage HCPs across the country. The objective was to engage 50,000 HCPs through Medical Learning Hub (MLH), and TC4A India worked to secure expert speakers, panelists and partner healthcare organizations on COVI D-19 topics.
Contact Email
[email protected]
Issued By
Medical Learning Hub (MLH)
Business Address
Tech Care for All India Pvt Ltd., D 107, Sector 2, Gautam Buddha Nagar
Uttar Pradesh, 201301, India
Country
India
Categories
Health · Medical
Last Updated
October 19, 2022
Report Abuse · Content Requests